Results 201 to 210 of about 181,938 (338)

Prospective observational study on Stelara (ustekinumab) assessing effectiveness in Crohn’s disease (PROSE): a 16-week follow-up [PDF]

, 2021
Anders Forss, Mark Clements, Pär Myrelid, Hans Strid, Charlotte Söderman, Agnieszka Wagner, David Andersson, Fredrik Hjelm, Ola Olén, Jonas F. Ludvigsson, Jonas Halfvarson, Jonas Halfvarson   +11 more
openalex   +1 more source

The influence of ultra‐processed foods on gut microbiome and inflammatory markers in schoolchildren from Northeastern Brazil

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objective This study investigated the relationship between the consumption of ultra‐processed foods (UPF), dietary profile, and inflammation on the intestinal microbiome in children. Methods A cross‐sectional study was conducted using data from a community‐based controlled trial involving 82 children aged 7–11 years enrolled in public schools ...
Cristiane Cosmo Silva‐Luis, Paulo César Trindade da Costa, Vinicius José Baccin Martins, José Luiz de Brito Alves   +3 more
wiley   +1 more source

Exploration of the Common Gene Characteristics and Molecular Mechanism of Parkinson’s Disease and Crohn’s Disease from Transcriptome Data [PDF]

, 2022
Haoran Zheng, Xiaohang Qian, Wotu Tian, Li Cao   +3 more
openalex   +1 more source

The attitudes and beliefs of Australasian pediatric gastroenterologists and dietitians toward the Crohn's disease exclusion diet

JPGN Reports, EarlyView.
Abstract Objectives Nutritional therapy plays a crucial role in managing pediatric Crohn's disease (CD). Exclusive enteral nutrition (EEN) is the primary induction therapy, achieving high remission and mucosal healing rates. However, its restrictive nature poses psychological and practical challenges.
Stephanie C. Brown, Emma Landorf, Nir Fireman, Anna Richards, Andrew S. Day   +4 more
wiley   +1 more source

P0197 Comparison of pharmacodynamic and mechanistic response of guselkumab intravenous and subcutaneous induction in moderately to severely active Crohn’s disease: molecular analysis of the GRAVITI and GALAXI Phase 3 studies [PDF]

Dylan Richards, Rickesh N. Patel, Kyung-Ah Sohn, Ailsa Hart, Tong Lee, J Liu, Cara Sisk, Mobolaji Olurinde, Natalie A. Terry, Bradford L. McRae, Walter Reinisch, B Feagan, Flavio Steinwurz, Remo Panaccione, Geert D’Haens, Patrick Branigan   +15 more
openalex   +1 more source

Can visceral adipose tissue and skeletal muscle predict recurrence of newly diagnosed Crohn’s disease in different treatments [PDF]

, 2022
Zinan Zhang, Xiaoyu Yu, Ning Fang, Xiuyan Long, Xixian Ruan, Jianing Qiu, Sifan Tao, Pan Gong, Kai Nie, An Li, Xiaoyan Wang, Li Tian   +11 more
openalex   +1 more source

A case of autoimmune hepatitis in a patient with inflammatory bowel disease and significant lymphadenopathy in the porta hepatis

JPGN Reports, EarlyView.
Abstract The diagnosis of autoimmune hepatitis (AIH) is supported by the presence of elevated transaminases, hypergammaglobulinemia, liver biopsy consistent with AIH, and the presence of AIH autoantibodies. In this case presentation, we highlight the challenges associated with diagnosing AIH in a patient with inflammatory bowel disease (IBD) who ...
Benjamin J. Malamet, Shannon Joerger, Karen Caudill, Mai He, Juan Reyes Genere, Janis Stoll   +5 more
wiley   +1 more source

Successful treatment of therapy-resistant metastatic Crohn's desiase with infliximab [PDF]

, 2004
CASTIGLIONE, FABIANA, COZZOLINO A, INSABATO, LUIGI, LEMBO, GIUSEPPE, PESCE, GIUSEPPE, RISPO A   +5 more
core   +1 more source

Cutaneous Crohn’s Disease

, 2011
Nooshin K. Brinster, Vincent Liu, A. Hafeez Diwan, Phillip H. McKee   +3 more
openalex   +1 more source

Expect the unexpected: A case of penetrating Crohn's disease complicated by foreign body ingestion

JPGN Reports, EarlyView.
Abstract A 17‐year‐old nonverbal male with autism spectrum disorder (ASD) presented with abdominal pain, diarrhea, and weight loss. Initial workup revealed penetrating Crohn's disease (CD) with an ileosigmoid fistula and abscess. After initial improvement with antibiotics, enteral nutrition (EN), and infliximab (IFX), he developed recurrent abdominal ...
Meredith R. Kline, Baddr A. Shakhsheer, Amelia Kellar   +2 more
wiley   +1 more source